Oncology PracticeHow New ICI Combos Change Bladder Cancer ManagementApril 15, 2024Genitourinary CancerImmunotherapyImmuno-oncologyPatient & Survivor Care
Oncology PracticeLess Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Oncology PracticeSubcutaneous Immunotherapy Promises Better Life For Cancer PatientsMarch 25, 2024Lung CancerImmunotherapyPatient & Survivor CarePractice Management
Oncology PracticeExtraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024ImmunotherapyPractice ManagementMixed TopicsMetastatic Breast CancerMelanomaSarcoma & GISTRenal Cell Carcinoma
Oncology PracticeSurvival Advantage of Adjuvant IO ‘Big News’ in Renal CancerMarch 13, 2024Gastrointestinal CancerGastroenterologyMelanomaImmunotherapy
Oncology PracticeTIL for Melanoma: What Are the Costs and Other Challenges to Getting It to Patients?March 8, 2024MelanomaImmunotherapyImmuno-oncologyPatient & Survivor CarePractice ManagementBusiness of MedicineMixed Topics
Oncology PracticeUnleashing Our Immune Response to Quash CancerFebruary 21, 2024Immuno-oncologyGene TherapyMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALL
Oncology PracticeA 74-year-old White male presented with a 1-year history of depigmented patches on the hands, arms, and face, as well as white eyelashes and eyebrowsFebruary 12, 2024MelanomaImmunotherapy
Oncology PracticeSmall PFS gain in metastatic prostate cancer with TKI and ICIJanuary 31, 2024Genitourinary CancerImmunotherapyPatient & Survivor CareProstate Cancer
Oncology PracticeHow the microbiome influences the success of cancer therapyDecember 5, 2023ImmunotherapyImmuno-oncologyPatient & Survivor Care
Oncology PracticeThese adverse events linked to improved cancer prognosisSeptember 28, 2023ImmunotherapyMelanomaLung CancerMixed Topics
Oncology PracticeImmunotherapy stewardship could save tens of millions a yearJuly 17, 2023ImmunotherapyImmuno-oncologyPractice Management
Hematology NewsCAR T-cell benefit in lenalidomide-refractory myelomaJune 23, 2023Multiple MyelomaImmunotherapyImmuno-oncology
Oncology PracticeWarts difficult to eradicate in immunocompromised childrenJune 21, 2023PediatricsImmunotherapy
Oncology PracticeAntibody-drug conjugate changes standard of care for platinum-resistant ovarian cancerJune 5, 2023Gynecologic CancerImmunotherapyImmuno-oncologyPatient & Survivor Care
